PSA vs RAPT · rev $1.23B vs $132.1M cap
PSA (PSA) versus RAPT Therapeutics Inc (RAPT) — a side-by-side from cached financials, not a winner call.
PSA (PSA) common stock.
RAPT Therapeutics Inc (RAPT) is a biotechnology company listed on US.
Latest reported PSA revenue for 2026-06-30 was $1.23B. Net income was $500.0M. Revenue was up 1.2% from 2026-03-31 to 2026-06-30. PSA currently screens at market cap $0.
Latest reported RAPT revenue for 2023-12-31 was $0. Net income was -$116.8M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. RAPT currently screens at market cap $132.1M.
PSA currently screens at market cap $0. RAPT currently screens at market cap $132.1M.
Not investment advice. Open the PSA and RAPT stock pages for the full models.
Not investment advice.